Economic Evaluation of Triflusal and Aspirin in the Treatment of Acute Myocardial Infarction

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.3, 2002-01, pp. : 195-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic evaluation of prasugrel for the treatment of myocardial infarction

By Coons James C Schwier Nicholas Harris Justin Seybert Amy L

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 4, 2014-04 ,pp. : 609-620

Informa Healthcare

Access to resources Recommend Favorite

Triflusal an alternative to aspirin after acute MI?

Inpharma, Vol. 1, Iss. 1234, 2000-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Triflusal cost saving in the treatment of acute MI

Inpharma, Vol. 1, Iss. 1332, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Triflusal cost saving in the treatment of acute MI

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 357, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Alcohol and Acute Myocardial Infarction

By Biyik I Ergene O

The Journal of International Medical Research, Vol. 35, Iss. 1, 2007-01 ,pp. : 46-51

Field House Publishing

Access to resources Recommend Favorite